Boston Scientific aims for confidence
624210
Boston Scientific Corp. chief executive James R. Tobin is putting his money where his mouth is.
606805
The graphics chipmaker is optimistic about the future, but competitors aren't standing still.
260447
Boston Scientific Corp.  on  Thursday issued preliminary sales and earnings results for the  third quarter that are below Wall Street expectations.
657657
Boston Scientific Corp. reported a 69 percent increase in sales and a doubling of earnings for the third quarter. The Natick, Mass.
290938
Boston Scientific Corp. BSX.N on   Thursday said an internal analysis confirmed an increased risk   of blood clots with its drug-coated device used to keep   previously clogged arteries open.
231996
The world's leading drug companies have promised to publish more data about clinical trials into new medicines to reassure the public about their safety.
188471
Drug manufacturers acknowledged Thursday that they face a crisis of credibility they hope to remedy by releasing information about their clinical trials.
121268
EPIX initiates a safety trial and gets good efficacy data.
685438
Plagued by chronic bad news about its marquee cardiovascular products, Boston Scientific Corp. yesterday moved to shift Wall Street's focus to a strong, solidly growing part of its business: Endoscopy products used in treating everything from kidney stones to throat and digestive-tract cancers.
570890
A US scientist has developed a 'double-barrelled' syringe could make blood tests more reliable.
512814
Boston Scientific Corp. said yesterday it sold $8.3 million worth of its Taxus drug-coated cardiac stents per day this month, a record level the Natick medical-devices giant said demonstrates it has won back doctors' confidence after three recalls.
470358
But a new analysis in a British journal includes some less clear-cut findings that may spell trouble for Boston Scientific.
647040
BOSTON Researchers have developed a simple urine test that appears to detect breast cancer early and accurately track tumor growth.
503333
Boston Scientific Corp. stock rose more than 5 per cent Wednesday after company executives called a recent recall of its Taxus heart stents a blip and said most of the lost market share has already been recovered.
359985
Business confidence in Massachusetts rebounded in December, with companies expecting improvements in the national economy and better prospects for sales and hiring, Associated Industries of Massachusetts reported. After slipping in November, AIM's business confidence index rose 3.3 points to 62 last month. Readings over 50 indicate that businesses are optimistic, considered a prerequisite for investment and hiring. Their view of ...
437108
A committee of renowned scientists said the result was a vote of confidence in medical research and a positive sign for Switzerland as a centre for science and research.
751523
A new addition to an already successful drug promises good results for investors.